Skip to main content
. 2018 Sep 27;13(9):e0204613. doi: 10.1371/journal.pone.0204613

Table 3. PCPs’ prescription frequency of treatments for chronic or recurrent LBP.

For each treatment, distribution of PCPs % (95% CI) according to the proportion of patients to whom they prescribe or recommend that treatment (upper quartile, inter quartile, lower quartile, none)
Proportion of patients receiving each treatment 76–100% 26–75% 1–25% 0%
Treatment prescribed or recommended
Acetaminophen 50.5 (46.2–54.7) 33.2 (29.4–37.4) 10.7 (8.4–13.7) 5.6 (3.9–7.9)
Physiotherapy 45.1 (40.0–49.3) 45.1 (40.0–49.3) 9.1 (6.9–11.8) 0.8 (0.3–2.0)
NSAIDs 31.7 (27.9–35.8) 51.0 (46.7–55.2) 14.7 (11.9–17.9) 2.6 (1.6–4.4)
Muscle relaxants 12.2 (9.7–15.3) 41.9 (37.8–46.2) 36.4 (32.4–40.6) 9.5 (7.3–12.3)
Manual therapy 11.1 (8.7–14.1) 28.8 (25.1–32.8) 40.4 (36.3–44.7) 19.7 (16.5–23.2)
Osteopathic treatment 8.8 (6.6–11.6) 33.9 (30.0–38.1) 44.5 (40.3–48.8) 12.7 (10.1–15.9)
Acupuncture 3.4 (2.1–5.4) 13.5 (10.8–16.7) 52.4 (48.1–56.6) 30.7 (26.9–34.8)
Chiropractic 2.8 (1.7–4.6) 17.5 (14.5–20.9) 51.6 (47.3–55.8) 28.2 (24.5–32.2)
Opioids 1.6 (0.8–3.1) 16.4 (13.4–19.8) 71.1 (67.1–74.8) 10.9 (8.5–13.9)
Spinal/nerve blocks 1.5 (0.7–3.0) 17.8 (14.7–21.3) 71.6 (67.6–75.2) 9.1 (6.9–11.9)

Missing values were handled by multiple imputation.

chronic or recurrent LBP = chronic or recurrent low back pain; PCPs = primary care physicians; NSAIDs = nonsteroidal anti-inflammatory drugs.